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Purpose: This investigation was designed to test the hypothesis that transforming growth 
factor-[~ a (TGF-Igl) regulates lysyl oxidase secretion from vascular smooth muscle cells. 
Lysyl oxidase is an enzyme that catalyzes an essential step in collagen and elastin 
cross-linking in the extracellular matrix, and TGF-[~I has been implicated in the patho- 
genesis of restenosis after vascular injury. The effect of TGF-[3 x on lysyl oxidase in 
vascular smooth muscle cells has not been previously defined. 
Methods: Rat aortic smooth muscle cells were grown in culture to confluence. Cells in 
passage 2 to 6 were incubated for 24 hours in media containing 0.1, 0.5, 1.0, or 10.0 
ng/ml  of TGF-J31. Lysyl oxidase activity in the media was quantitated with a tritium- 
release bioassay against an insoluble 3H-labeled aortic elastin substrate. Northern blot 
analyses were performed to determine steady-state levels of lysyl oxidase mRNA in the 
smooth muscle cells. 
Results: Lysyl oxidase activity in the media increased 1.5-fold above control levels after 
exposure to 10 ng/ml  of TGF-[g 1 (p < 0.01). This increase in lysyl oxidase activity was 
associated with a concentration-dependent increase in steady-state levels of lysyl oxidase 
mRNA, being 4.3- and 6.2-fold above control levels after exposure to 1 and 10 ng/ml  
TGF-[31, respectively (p < 0.01). The observed increase in steady-state lysyl oxidase 
mRNA after exposure to TGF-[~ was also time-dependent over the 24-hour experimen- 
tal period, 
Conclusions: TGF-~I appears to regulate lysyl oxidase in cultured rat aortic smooth muscle 
cells. Increases in lysyl oxidase activity may be one of the mechanisms by which TGF-[~ 
contributes to arterial restenosis after vascular injury. (J Vase Surg 1997;25:446-52.) 
Arterial restenosis after vascular injul T is charac- 
terized by migration and proliferation of smooth 
muscle cells with abundant synthesis of extracellular 
matrix. Extracellular matrix proteins are a major 
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component ofthcse restenotic lesions, but regulation 
of their synthesis remains poorly understood. 
Lysyl oxidasc is an important enzyme in matrix 
biology. It is secreted by various cells including vas- 
cular smooth muscle. Lysyl oxidase catalyzes a critical 
step in collagen and elastin cross-linldng. In the ex- 
tracellular matrix it selcctively oxidizes peptidyl lysine 
residues in collagen and elastin to yield peptidyl alde- 
hydes that serve as precursors for the formation of 
covalent cross-links. 1 This enzymatic step is likely to 
be an important site for the regulation of extracellu- 
lar matrix synthesis and is essential in the stabilization 
of collagen and elastin. 
Transforming rowth factor-[31 (TGF-[31) is a 
recognized regulatory molecule in certain tissue re- 
pair processes characterized by increased synthesis of 
extracellular matrix proteins. 2 Balloon injury of the 
rat carotid artery increases TGF-[31 mRNA in the 
vessel wall, and neutralizing antibodies to TGF-J31 
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inhibit subsequent luminal narrowings, ,4 Moreover, 
administration fTGF-[31 increases extracellular ma- 
trix accumulation after balloon injury of the rabbit 
carotid artery.s Finally, in situ hybridization has dem- 
onstrated increased TGF-[31 mRNA in restenotic hu- 
man coronary artery lesions. 6 Therefore it appears 
that TGF-[~I may be important in the regulation of 
extracellular matrix synthesis after arterial injury in 
both experimental nimals and humans. 
TGF-[31 is also known to regulate lysyl oxidase in 
rat lung fibroblasts. 7 TGF-[3~ has been shown to 
regulate xtracellular matrix synthesis after bleomy- 
cin-induced pulmonary injury? ,8,9 If it exerts a simi- 
lar effect on lysyl oxidase in vascular smooth muscle, 
then increases in lysyl oxidase activity may be one 
mechanism by which TGF-[31 contributes to arterial 
resten0sis after vascular injury. The purpose of  this 
investigation was to determine whether TGF-[~ 1 reg- 
ulates lysyl oxidase in cultured rat vascular smooth 
muscle cells. 
METHODS 
Cell culture. Rat aortic smooth muscle cells 
were isolated and cultured? ° In brief, the aortic 
arches and descending thoracic aortae from adult 
male Sprague-Dawley rats (Harlan Laboratories, In- 
dianapolis, Ind.) were excised aseptically and placed 
in phosphate-buffered saline solution (Gibco, Grand 
Island, N. Y.). Fat and connective tissue were re- 
moved by dissection. The vessels were then opened 
longitudinally and preincubated for 20 minutes at 
37 ° C in phosphate-buffered saline solution contain- 
ing 0.1% collagenase (Type IV, Worthington Bio- 
chemical Corporation, Freehold, N. J.), 0.05% elas- 
tase (type 1, Sigma, St. Louis, Mo.), 0.1% soy bean 
trypsin inhibitor (Sigma), penicillin (100 U/ml) ,  
and streptomycin (100 ~tg/ml). After preincubation 
was performed, the advcntitia was carefully removed 
and the luminal surface scraped to remove endothe- 
lial cells. The vessels were subsequently placed in 
identical fresh enzyme solution, minced into 1 mm 2 
pieces, and incubated for an additional 2 hours at 
37°C with timration at  30-minute intervals. After 
this incubation was performed, 10% fetal bovine se- 
rum (Hyclone Laboratories, Logan, Utah) was 
added to inactivate the enzymes, and the suspension 
was centrifuged at 200g for 5 minutes. The superna- 
rant was discarded, and the pellet was resuspended in 
fresh Dulbecco's modified Eagle's medium (Gibco) 
containing 10% fetal bovine serum, 0.68 mmol /L  
L- glutamine, penicillin (100 U/ml) ,  and streptomy- 
cin (100 ~tg/ml). 
Smooth muscle cells derived in this manner were 
immediately seeded at a constant density in plastic 
culture flasks and incubated at 37 ° C in a humidified 
.atmosphere (95% air, 5% CO2). The culture medium 
was removed and replaced with fresh medium three 
times weekly. At confluence the cells were harvested 
for passage with a solution containing 0.05% trypsin 
and 0.02% ethylenediamine tetraacetic acid (Gibco). 
Smooth muscle cell identity was confirmed on cells 
during second passage by an immunofluorescence 
assay with monoclonal antibodies specific to smooth 
muscle c~-actin (Sigma) and the typical histomorpho- 
logic characteristics were documented. 
Confluent cultures at passage 2 to 6 were incu- 
bated for 24 hours in fresh serum-free Dulbecco's 
modified Eagle's medium containing 0.2% bovine 
serum albumin (Sigma) and antibiotics. This me- 
dium was then removed and replaced with fresh 
serum-free medium containing TGF=[31 (0.1-, 0.5-, 
1-, or 10-ng/ml concentrations) or a control vehicle. 
Cells were then incubated in the presence or absence 
of TGF-~ 1. Lysyl oxidase activity in the conditioned 
medium was determined after incubation in the pres- 
ence or absence of TGF-[31 was performed for 24 
hours. Steady-state l vels of lysyl oxidase mRNA in 
rat aortic smooth muscle cells were determined after 
incubation for 2, 6, 12, or 24 hours was performed in 
the presence or absence ofTGF-[31. 
Lysyl oxidase activity assays. Assays of aliquots 
of conditioned media were obtained for lysyl oxidase 
activity with a modification of a tritium-release bioas- 
say. 1113 In brief, after incubation was performed for 
24 hours in the presence of TGF-[31 or a control 
vehicle, the medium was removed, supplemented 
immediately with 0.1 mmol /L  phenylmethanesulfo- 
nyl fluoride to inhibit serine proteases, and storea at 
-70  ° C for later assay. Storage at -70  ° C did not 
affect lysyl oxidase activity (data not shown). The 
cultivated smooth muscle cells were rinsed three 
times with sterile phosphate-buffered saline solution, 
and cellular protein was then extracted in 1% sodium 
dodecyl sulfate. Extracts were stored at -70  ° C for 
subsequent protein quanutation with a spectromet- 
ric assay (BCA Reagent, Sigma). 
Lysyl oxidase activity was determined in aliquots 
of the conditioned media against a saline-insoluble 
3H-labeled aortic elastin substrate. This substrate 
was prepared from 17-day chick embryo aortas that 
had been labeled in organ culture with [4,5 3H]-L- 
lysine (New England Nuclear, Boston, Mass.) as pre- 
viously described. 12 Each enzyme activity assay in- 
cluded 0.5 ml of conditioned medium as the enzyme 
source, 125,000 cpm of3H-elastin substrate, and 0.1 
mol /L  sodium borate/0.15 mol /L  sodium chloride 
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Fig. 1. Effect of TGF-[~I on lysyl oxidase nzyme activity 
secreted into media by cultured rat aortic smooth muscle 
cells. Confluent cultures were arrested in serum-free media 
for 24 hours and subsequently incubated for additional 24 
hours in fresh, serum-free medium supplemented with 0.1, 
0.5, 1.0, and l0 ng/ml ofTGF-J31 or control vehicle. Data 
are pooled mean + SEM of [3-aminoproprionitrile-inhib- 
ited activity from triplicate aliquots of conditioned media 
derived from triplicate cultures for each condition. BAPN, 
[3-aminoproprionitrile; TGF, transforming growth factor. 
in a final volume of 0.75 ml at a pH of 8.0. Assays for 
each condition were performed after incubation pe- 
riods of 12 hours at 37 ° C in an orbital shaker in the 
presence or absence of 50 ~m f3-aminoproprionitrile 
(BAPN). After this incubation was performed, assay 
reactions were stopped on ice at 4 ° C. Solutions were 
spun in a centrifuge at 15,600g for 5 minutes at 4 ° C 
to pellet the bulk of the 3H-elastin substrate. Four 
hundred microliter aliquots of the supernatant were 
transferred to 5000 molecular weight cutoff mi- 
croconcentrating filters (Millipore, Burlington, Md.) 
and were spun in a centrifuge at 5000g for 60 min- 
utes at 4 ° C. To measure tritium released from the 
substrate, 100 ~xl of the ultrafiltrate was counted in a 
liquid scintillation counter. All lysyl oxidase activities 
reported were fully inhibited by the presence of 50 
~m BAPN in the assay reactions and were normal- 
ized to total cellular protein. Triplicate assays were 
performed on triplicate cultures for each experimen- 
tal condition tested. 
Northern analysis. Northern hybridization was 
performed on total cellular RNA isolated from rat 
aortic smooth muscle cells 2,9,14, as a means of deter- 
mining the effect of TGF-[31 on steady-state l vels 
of lysyl oxidase mRNA. In brief, total cellular RNA 
was extracted in a solution of guanidine isothiocya- 
nate, centrifuged, and purified as previously de- 
scribed. 2,9,14 Equal amounts of RNA, 15 ~Lg/lane, 
were separated by electrophorcsis on 1% agarose gels 
containing formaldehyde. Uniformity of loading was 
confirmed by examination of 28S, I8S rRNA bands 
on separate ethidium bromide-stained minigels. 
RNA was then transferred over a 12- to 18-hour 
period to nitrocellulose filters that were subsequently 
baked, prehybridized, and hybridized with 3' end- 
labeled oligonucleotide antisense probes for rat lysyl 
oxidase. Autoradiograms were developed from these 
blots, and radioactivity was quantified by radioactive 
image analysis. 
The oligonucleotide probes (5'-AGG-CAC-CAG- 
GTA-GCT-GGG-GTT-TAC-ACT-GAC-3') used for 
these blots were synthesized on the basis of the 
published sequence for rat lysyl oxidase and were 
complementary to nucleotides 1108 to 1137 of the 
eDNA for lysyl oxidase, is The probes were synthe- 
sized on an automated DNA synthesizer and purified 
by high-performance liquid chromatography before 
use .  
RESULTS 
Effect of  TGF-~I on lysyl oxidase enzyme ac- 
tivity. TGF-[31 significantly increased lysyl oxidase 
activity from rat vascular smooth muscle cells (Fig. 
1). In the presence of 10 ng/ml  of TGF-~31, lysyl 
oxidase activity increased 1.5-fold above control ev- 
els (p < 0.01, Student's t test). In contrast, in the 
presence of  i ng/ml  TGF-[~I, lysyl oxidase activity 
increased only 1.2-fold above control evels (p = 0.1, 
Student's t test). These results suggest the presence 
of a concentration-dependent effect of TGF-~I on 
lysyl oxidase secretion by cultured rat aortic smooth 
muscle cells. Additional experiments demonstrated 
that lysyl oxidase activity secreted into the media 
after exposure to TGF-[31 increased in a linear fash- 
iort over a 24-hour exposure period (data not 
shown). 
Effect of  TGF-I~I on lysyl oxidase mRNA. 
TGF-[31 significantly increased steady-state of lysyl 
oxidase mRNA in cultured rat vascular smooth mus- 
cle cells (Fig. 2). In the presence of 1 and 10 ng/ml  
TGF-[31, lysyl oxidase mRNA increased 4.3- and 
6.2-fold, respectively (p < 0.01, Student's t test). 
These results suggest existence of a concentration- 
dependent effect of TGF-[~1 on lysyl oxidase mRNA. 
The time course of smooth muscle cell lysyl oxi- 
dase mRNA expression i  the presence of 1 ng/ml  of 
TGF-f31 was determined at 2, 6, 12, and 24 hours 
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Fig. 2. Concentration-dependent effect of TGF-J31 on steady-state l vels of lysyl oxidase 
mRNA in cultured rat aortic smooth muscle cells. Total cellular RNA was extracted, purified, 
and subjected to Northern blot analysis with 32p labeled oligonucleotide probes complemen- 
tary to unique sequence of cDNA for rat lysyl oxidase. A, Autoradiogram ofNorthern blot of 
total cellular RNA (15 ~g/lane) derived from cells incubated for 24 hours inpresence of 0.1, 
0.5, 1.0, and 10 ng/ml ofTGF-[31 or control vehicle. Each lane represents RNA ample from 
single culture. B, Radioactive image analysis of Northern blot in A. Data are pooled mean + 
SEM of activities from three lanes per condition. 
(Fig. 3). Smooth muscle lysyl oxidase mRNA in- 
creased significantly to 3.8- and 14.3-fold above con- 
trol levels by 12 and 24 hours, respectively (p< 0.01, 
Student's t test). These results demonstrate hat the 
effect of TGF-[31 on lysyl oxidase mRNA appears to 
be time-dependent. 
DISCUSSION 
This investigation, which is an expansion of an 
earlier preliminary report by the authors, 16 docu- 
mented that TGF-~31 increases lysyl oxidase activity 
in the medium of cultured rat aortic smooth muscle 
cells. This increase in enzyme activity was associated 
with concentration-dependent and time-dependent 
increases in steady-state levels of lysyl oxidase 
mRNA.These data provide the first in vitro evidence 
that TGF-131 regulates lysyl oxidase secretion from 
vascular smooth muscle. 
Tissue repair after injury is characterized by abun- 
dant synthesis of extracellular matrix proteins includ- 
ing collagen and elastin. However, multiple post- 
translational modifications are necessary to stabilize 
these proteins within the matrix. It is reasonable to 
assume that collagen and elastin synthesis must be 
coordinately regulated with production of those en- 
zymes involved in their posttranslational processing. 
Because lysyl oxidase catalyzes an essential enzymatic 
step in collagen and elastin cross-linking, it is possible 
that increased collagen and elastin biosynthesis i
accompanied by corresponding increases in lysyl ox- 
idase activity. 
This later tenet is well illustrated in animal mod- 
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Fig. 3. Time-dependent effect of TGF-[31 on steady-state levels of lysyl oxidase mRNA in 
cultured rat aortic smooth-muscle ells. Total cellular RNA was extracted, purified, and 
subjected to Northern blot analysis with 32p-labeled oligonucleotide probes complementary to 
unique sequence of eDNA for rat lysyl oxidase. A, Autoradiogram ofNorthern blot of total 
cellular RNA (15 ~g/lane) derived from cells cultured in presence of 1 ng/ml. B, Radioactive 
image analysis of Northern blot in A. Data are mean -+ SEM for 2 or 3 lanes per condition. 
els of pulmonary fibrosis. For example, acute lung 
injury after intratracheal dministration fNeomycin 
or cadmium chloride in rats increases not only lung 
collagen synthesis but also lung lysyl oxidase activi- 
ty. 17-19 However, whereas lysyl oxidase activity is 
maximal within the first 3 to 5 days after acute lung 
injury, collagen synthesis does not become maximal 
for 2 weeks. 14,2° It is also noteworthy that BAPN, an 
irreversible inhibitor of lysyl oxidase, actually pro- 
motes collagen degradation when administered be- 
fore cadmium chloride exposure in hamsters. 21
These earlier pulmonary experiments support the 
tenet that increases in lysyl oxidase activity will pro- 
mote collagen synthesis and that decreases in lysyl 
oxidase activity will inhibit collagen accumulation i
the injured lung. 
If one assumes imilar coordinate regulation of 
extracellular matrix proteins and the enzymes in- 
volved in their posttranslational processing exists in 
the vascular wall, then it is possible that reductions in 
lysyl oxidase activity may lessen collagen and elastin 
accumulation after arterial injury occurs. Consistent 
with this hypothesis are the results Of a recent study 
in which BAPN administration significantly inhibited 
restenosis after laser balloon angioplasty was per- 
formed in rabbitsY 
Several recent studies of rat lung fibroblasts pro- 
vide additional insight into the regulation of lysyl 
oxidase in vascular smooth muscle cells. For example, 
in cultured rat lung fibroblasts bleomycin increased 
not only steady-state l vels of TGF-[31 mRNA but 
also TGF-[31 activity in the conditioned medium. 2s 
In similar studies involving rat lung fibroblasts 
TGF-[31 increased lysyl oxidase mRNA, protein, and 
activity. 7 Thus TGF-[31 may be an important regula- 
tory molecule for lysyl oxidase production in rat lung 
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fibroblasts. In this investigation of cultured rat aortic 
smooth muscle cells, TGF-[31 increased both lysyl 
oxidase mRNA and enzyme activity. Therefore rat 
lung fibroblast  and vascular smooth-muscle c lls be- 
have similarly in vitro with respect to the regulation 
oflysyl oxidase after exposure to TGF-[31. 
Given these similarities between rat lung fibro- 
blasts and vascular smooth muscle cells in vitro, it is 
relevant to note the similarities between the lung and 
the vascular wall with respect to the kinetics of extra- 
cellular matrix protein expression after injury in vivo. 
In this regard bleomycin-induced lung injury in rats 
caused maximal procollagen mRNA and collagen 
synthesis approximately 2 weeks after injury. 14'20 
Moreover, in similar studies in mice and hamsters 
TGF-[31 mRNA increased before procollagen 
mRNA.  24,2s Similarly, after balloon injury of the ca- 
rotid artery was performed in rats, both procollagen 
and tropoelastin mRNA levels were greatest approx- 
imately 2 weeks after injury. 26 Furthermore TGF-[31 
mRNA levels were increased within hours of arterial 
injury, reached a maximum by 24 hours, and re- 
mained significantly elevated for approximately 2 
weeks? Thus the relationship ofTGF-[31 to extracel- 
lular matrix protein production after injury appears 
similar in the lung and the vascular wall. 
When the similarities between the lung and the 
vascular wall in light of the results of this investiga- 
tion are considered, it is tempting to speculate that 
the reduction in restenosis after administration of 
neutralizing antibodies to TGF-[31 may be due in 
part to a reduction in lysyl oxidase activity. Such a 
reduction in lysyl oxidase activity, by preventing sta- 
bilization and accumulation ofcollagen and elastin in 
the neointima, would lessen accumulation of extra- 
cellular matrix and hence neointimal thickening. It is 
possible that pharmacologic or genetic modulation 
of lysyl oxidase may have important therapeutic m- 
plications in the prevention ofrestenosis after arterial 
injury. 22 
Finally, like collagen and elastin the formation 
and maturation of lysyl oxidase is also dependent on 
a variety of posttranslational modif icat ions.  27Theo- 
retically, increases in lysyl oxidase activity might re- 
sult from effects ofTGF-[31 on posttranslational pro- 
cessing of the enzyme rather than increases in the 
nascent protein. However, irrimunopreciptation 
studies in rat lung fibroblasts have demonstrated that 
TGF-[31 increases both the lysyl oxidase precursor 
and its proteolytically processed erivatives to a sim- 
ilar extent. 7 The results of the latter studies sug- 
gested that the effect of TGF-[31 on lysyl oxidase 
activity was related to increases in steady-state levels 
oflysyl oxidase mRNA rather than specific effects on 
posttranslational processing. This investigation pro- 
vides additional evidence that the effect of TGF-~l 
on lysyl oxidase activity is due to increases in steady- 
state mRNA levels. However, data from this study do 
not specifically preclude the possibility of additional 
effects ofTGF-[31 on posttranslational processing of 
lysyl oxidase in vascular smooth muscle. Nevertheless 
increases in lysyl oxidase activity may be one of the 
mechanisms by which TGF- [31 contributes to arterial 
restenosis after vascular injury. 
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